Medicamen Biotech Limited announced that at its board meeting held on May 25, 2022, recommended a final dividend at 10% on equity shares of INR 10 each that is INR 1 per equity share for the financial Year 2021-22.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
518.6 INR | -0.67% | -2.24% | -13.93% |
1st Jan change | Capi. | |
---|---|---|
-13.93% | 79.38M | |
+18.04% | 42.95B | |
+16.92% | 21.38B | |
+18.33% | 15.05B | |
+19.27% | 14.45B | |
+56.12% | 13.04B | |
-0.05% | 6.79B | |
-10.73% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- MEDICAMEQ Stock
- News Medicamen Biotech Limited
- Medicamen Biotech Limited Recommends Final Dividend for the Financial Year 2021-22